Academic Radiology
Volume 17, Issue 2 , Pages 157-162, February 2010

Effect of Improving the Quality of Radiographic Interpretation on the Ability to Predict Pulmonary Tuberculosis Relapse

  • Jason E. Stout, MD, MHS

      Affiliations

    • Division of Infectious Diseases & International Health, Department of Medicine, 3306-Duke University Medical Center, Durham, NC 27710
    • Corresponding Author InformationAddress correspondence to: J.E.S.
    • ,
  • Andrzej S. Kosinski, PhD

      Affiliations

    • Department of Biostatistics and Bioinformatics, 3306-Duke University Medical Center, Durham, NC 27710
    • ,
  • Carol Dukes Hamilton, MD, MHS

      Affiliations

    • Division of Infectious Diseases & International Health, Department of Medicine, 3306-Duke University Medical Center, Durham, NC 27710
    • ,
  • Philip C. Goodman, MD

      Affiliations

    • Division of Thoracic Imaging, Department of Radiology, 3306-Duke University Medical Center, Durham, NC 27710
    • ,
  • Ann Mosher, MPH, FNP

      Affiliations

    • Division of Infectious Diseases & International Health, Department of Medicine, 3306-Duke University Medical Center, Durham, NC 27710
    • ,
  • Dick Menzies, MD

      Affiliations

    • Montreal Chest Institute, McGill University, Montreal, Quebec, Canada
    • ,
  • Neil Schluger, MD

      Affiliations

    • Division of Pulmonary Allergy & Critical Care Medicine, Columbia University College of Physicians & Surgeons, New York, NY
    • ,
  • Awal Khan, PhD

      Affiliations

    • Centers for Disease Control and Prevention, Atlanta, GA
    • ,
  • John L. Johnson, MD

      Affiliations

    • Division of Infectious Diseases, Case Western Reserve University, Cleveland, OH
    • ,
  • Tuberculosis Trials Consortium

Received 31 July 2009; accepted 10 August 2009. published online 12 November 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 USPHS/TB Trials Consortium Study 22 was sponsored by the United States Centers for Disease Control and Prevention and was funded in part through a Memorandum of Understanding between the CDC and the Washington, D.C. Veterans Affairs Medical Center. Hoechst Marion Roussel, the manufacturer of rifapentine, provided rifapentine and contributed to the cost of 3 investigator meetings, but did not participate in original or secondary analysis study design, data collection, data analysis, data interpretation, or writing of the report. Dr. Stout received salary support from the National Institutes of Health (K23AI051409). Dr. Hamilton also received salary support from the National Institutes of Health (K24AI001833).

PII: S1076-6332(09)00503-0

doi:10.1016/j.acra.2009.08.013

Academic Radiology
Volume 17, Issue 2 , Pages 157-162, February 2010

Article Tools

* Image Usage & Resolution